Literature DB >> 20391683

[Helicobacter pylori infection: from gastric to systemic disease].

Giovanni Gasbarrini1, Simona Racco, Francesco Franceschi, Luca Miele, Giovanni Cammarota, Antonio Grieco, Antonio Gasbarrini.   

Abstract

H. pylori infection, through a chronic stimulation of the immune system and the occurrence of molecular mimicry mechanisms, is responsible for the majority of the gastroduodenal diseases and also for some extragastric disorders, including sideropenic anemia and idiopathic thrombocytopenic purpura; other diseases are under investigation.

Entities:  

Mesh：

Year:  2010        PMID： 20391683

Source DB:  PubMed          Journal:  Recenti Prog Med        ISSN： 0034-1193


  5 in total

1.  Higher serum levels of rheumatoid factor and anti-nuclear antibodies in helicobacter pylori-infected peptic ulcer patients.

Authors:  Abdollah Jafarzadeh; Maryam Nemati; Mohammad Taghi Rezayati; Mansooreh Nabizadeh; Medhi Ebrahimi
Journal:  Oman Med J       Date:  2013-07

Review 2.  Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review.

Authors:  Reza Ghotaslou; Hamed Ebrahimzadeh Leylabadlo; Yalda Mohammadzadeh Asl
Journal:  World J Methodol       Date:  2015-09-26

Review 3.  Culture-guided treatment approach for Helicobacter pylori infection: review of the literature.

Authors:  Giovanni Cammarota; Gianluca Ianiro; Stefano Bibbò; Teresa Antonella Di Rienzo; Luca Masucci; Maurizio Sanguinetti; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

4.  Optimized high-dose amoxicillin-proton-pump inhibitor dual therapies fail to achieve high cure rates in China.

Authors:  Jia-Li Hu; Jun Yang; Yin-Bin Zhou; Ping Li; Ran Han; Dian-Chun Fang
Journal:  Saudi J Gastroenterol       Date:  2017 Sep-Oct       Impact factor: 2.485

5.  Utility of normalized genome quantification of Helicobacter pylori in gastric mucosa using an in-house real-time polymerase chain reaction.

Authors:  Ana Morilla; Santiago Melón; Marta E Álvarez-Argüelles; Edisa Armesto; Henar Villar; María de Oña
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.